Hsa-miR-2113-5p is not a key indicator for coronary artery disease: a case-controlled observational study

Meisam Rostaminasab Dolatabad1, Tayebeh Sadeghi2, Zahra Taheri3

  • 1Department of Medicine, Kerman Branch, University of Islamic Azad, Kerman, Iran.

PubMed

Insights

This study found no significant difference in hsa-miR-2113-5p or Interferon lambda 1 (IFN-λ1) levels in patients with coronary artery disease (CAD). These molecules do not appear to be involved in the chronic inflammation associated with CAD.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Immunology

Background:

  • Coronary artery disease (CAD) is a widespread inflammatory condition.
  • Interferon lambda 1 (IFN-λ1) is implicated in inflammatory diseases, but its role in CAD is unclear.
  • Bioinformatic analysis suggested hsa-miR-2113-5p may target IFN-λ1.

Purpose of the Study:

  • To investigate the expression levels of hsa-miR-2113-5p in CAD patients.
  • To examine the correlation between hsa-miR-2113-5p and IFN-λ1 expression in CAD.
  • To determine the potential role of hsa-miR-2113-5p and IFN-λ1 in CAD pathogenesis.

Main Methods:

  • Real-time polymerase chain reaction (PCR) was used to measure gene expression.
  • The study included 40 individuals with CAD and 20 healthy controls.
  • Expression levels of hsa-miR-2113-5p and IFN-λ1 were analyzed.

Main Results:

  • No significant differences in hsa-miR-2113-5p or IFN-λ1 expression were observed between CAD patients and controls.
  • No correlation was found between hsa-miR-2113-5p, IFN-λ1, and age in either group.
  • The study did not find a link between these molecules and CAD status.

Conclusions:

  • The chronic inflammation in CAD appears to be independent of hsa-miR-2113-5p and IFN-λ1.
  • Further research may be needed to identify other molecular regulators in CAD.
  • These findings suggest hsa-miR-2113-5p and IFN-λ1 are not key players in CAD-related inflammation.
Abstract